...human growth hormone. The trial found that it was possible to give a dosage once every two weeks, instead of daily. Merck & Co. (NYSE: MRK), which uses the CTP peptide in fertility treatments, has obtained certification for its product, Elovna. This approval...
• Pharma News
Powered By DaylifeOther company news pages:
- Abbott Labs
- Amgen
- AstraZeneca
- Bristol-Myers Squibb
- Eli Lilly
- Glaxo
- Roche
- J&J
- Merck
- Novartis
- Pfizer
- Sanofi-Aventis
- Schering-Plough
- Wyeth
Merck & Company, Inc. News
Preventive Medicine: Buying Health Stocks Before Overhaul
...of the $1.3 billion Putnam Global Healthcare Fund (PHSTX), says the diversified global fund's assets are invested based on a company's fundamentals, not by making macro calls on issues such as health-care legislation. But Ms. Chen does see some health-care...
Jades legacy
...licensed, which countries are using it; everything,â said Fikri. Gardasil, manufactured by Merck, is now the German pharmaceutical companyâs top-selling vaccine, while Cervarix is made by the British group GlaxoSmithKline. Gardasil protects against four...
Your Health: New methods may boost allergy shots
...and medicine at the University of Tennessee Health Science Center in Memphis. Blaiss, a consultant to the drug's maker, Merck, presented the data at a recent meeting of the American Academy of Allergy, Asthma & Immunology. A study in adults found similar results,...
Nanotech robots deliver gene therapy through blood
...as a key player in the disease process. Dozens of biotechnology and pharmaceutical companies including Alnylam
Industry relationships with physicians are coming under fire
...version of healthcare reform bills. Some pharmaceutical companies â specifically Cephalon, GlaxoSmithKline, Lilly, and Merck â have already begun disclosing lists of payments to physicians on company Web sites, with more companies said to be following suit....
Deadbeat Stock #5: Merck (MRK)
...new drugs, but, in reality, they cannot make up for the lost revenue from Zocor. Merck's (MRK) revenues are stagnant and the company has a very weak pipeline. Even if health care reform adds more patients, it will also bring increased pressure to cut prices. If...
Kilitch Drugs floats new arm for eye-care biz
...contract manufacturing services and supplies to big pharmaceutical firms, including Ranbaxy, Zydus Cadila, Emcure, USV, E-Merck and Piramal Healthcare. It has manufacturing locations at Poanta Sahib in Himachal Pradesh, Navi Mumbai and Thane. - PTI ...
New B+L leadership ready to 'power up'
Schering-Plough Corp. was in trouble. The New Jersey-based pharmaceutical and consumer products company, home of the allergy meds Nasonex and Claritin, was hemorrhaging market share in 2003, seeing its profits fall and facing costly manufacturing and
Longer-lasting drug co Prolor raises $24.4m
...by the body. Prolor has the rights to use the peptide for all indications, except for fertility treatments. During 2009, the company carried out a trial on monkeys of beta interferon drugs for the treatment of multiple sclerosis. The study found that the CTP...
News page is in maintenance. Sorry for the inconvenience.
Clear
Clear